Biologics & Biosimilars Market Report

China Biologics & Biosimilars Industry Market Research Report 2023-2029

  • POSTDATE：Oct 10, 2023
  • PAGES：193
  • REPORT CODE：GMM1842585
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Biologics & Biosimilars industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Biotech Pharma

    • Merck

    • Gelgen Biopharma

    • Changchun High Tech

    • Teva

    • fizer

    • CP Guojian Pharmacy

    • Mylan

    • AbbVie

    • Johnson & Johnson

    • Sanofi

    • Hospira

    • Novo Nordisk

    • Lilly

    • Roche

    • 3sbio

    By Type:

    • Non-Patented Biological Reagents

    • Hormone

    • Antibiotic

    • Other

    • Enzyme

    By Application:

    • Diabetes

    • Cardiovascular

    • Tumor

    • Other

    • Hemophilia

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Biologics & Biosimilars Market Overview 2018-2029

    • 1.1 China Biologics & Biosimilars Industry Development Overview

    • 1.2 China Biologics & Biosimilars Industry Development History

    • 1.3 China Biologics & Biosimilars Industry Market Size (2018-2029)

    • 1.4 China Biologics & Biosimilars Market Analysis by Type from Production Side

      • 1.4.1 China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Non-Patented Biological Reagents (2018-2029)

      • 1.4.2 China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Hormone (2018-2029)

      • 1.4.3 China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Antibiotic (2018-2029)

      • 1.4.4 China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.5 China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Enzyme (2018-2029)

    • 1.5 China Biologics & Biosimilars Market Analysis by Application from Consumption End

      • 1.5.1 China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

      • 1.5.2 China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

      • 1.5.3 China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Tumor (2018-2029)

      • 1.5.4 China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.5 China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Hemophilia (2018-2029)

    • 1.6 China Biologics & Biosimilars Market Analysis by Region

      • 1.6.1 North China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    Chapter 2 China Biologics & Biosimilars Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Biologics & Biosimilars Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Biologics & Biosimilars Market Status and Competition Analysis in 2023

      • 2.2.3 China Biologics & Biosimilars Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Biologics & Biosimilars Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Biologics & Biosimilars Industry Development

    Chapter 3 Biologics & BiosimilarsIndustry Chain Analysis

    • 3.1 Biologics & Biosimilars Industry Chain

    • 3.2 Biologics & Biosimilars Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Biologics & Biosimilars Market

    • 3.3 Biologics & Biosimilars Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Biologics & Biosimilars Market

    Chapter 4 China Biologics & Biosimilars Market, by Type

    • 4.1 China Biologics & Biosimilars Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Biologics & Biosimilars Total Production Volume and Growth Rate from Production Side

    • 4.5 China Biologics & Biosimilars Production Volume and Growth Rate, by Type

      • 4.5.1 China Biologics & Biosimilars Production Volume and Growth Rate of Non-Patented Biological Reagents

      • 4.5.2 China Biologics & Biosimilars Production Volume and Growth Rate of Hormone

      • 4.5.3 China Biologics & Biosimilars Production Volume and Growth Rate of Antibiotic

      • 4.5.4 China Biologics & Biosimilars Production Volume and Growth Rate of Other

      • 4.5.5 China Biologics & Biosimilars Production Volume and Growth Rate of Enzyme

    Chapter 5 China Biologics & Biosimilars Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Biologics & Biosimilars Total Market Size and Growth Rate from Consumption End

    • 5.5 China Biologics & Biosimilars Market Size and Growth Rate, by Application

      • 5.5.1 China Biologics & Biosimilars Market Size and Growth Rate of Diabetes

      • 5.5.2 China Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular

      • 5.5.3 China Biologics & Biosimilars Market Size and Growth Rate of Tumor

      • 5.5.4 China Biologics & Biosimilars Market Size and Growth Rate of Other

      • 5.5.5 China Biologics & Biosimilars Market Size and Growth Rate of Hemophilia

    Chapter 6 China Biologics & Biosimilars Market, by Region

    • 6.1 China Biologics & Biosimilars Production Volume and Production Value, by Region

    • 6.2 China Biologics & Biosimilars Sales Volume and Sales Value, by Region

    Chapter 7 North China Biologics & Biosimilars Market Analysis

    • 7.1 North China Biologics & Biosimilars Market, by Type

    • 7.2 North China Biologics & Biosimilars Market, by Application

    Chapter 8 Central China Biologics & Biosimilars Market Analysis

    • 8.1 Central China Biologics & Biosimilars Market, by Type

    • 8.2 Central China Biologics & Biosimilars Market, by Application

    Chapter 9 South China Biologics & Biosimilars Market Analysis

    • 9.1 South China Biologics & Biosimilars Market, by Type

    • 9.2 South China Biologics & Biosimilars Market, by Application

    Chapter 10 East China Biologics & Biosimilars Market Analysis

    • 10.1 East China Biologics & Biosimilars Market, by Type

    • 10.2 East China Biologics & Biosimilars Market, by Application

    Chapter 11 Northeast China Biologics & Biosimilars Market Analysis

    • 11.1 Northeast China Biologics & Biosimilars Market, by Type

    • 11.2 Northeast China Biologics & Biosimilars Market, by Application

    Chapter 12 Southwest China Biologics & Biosimilars Market Analysis

    • 12.1 Southwest China Biologics & Biosimilars Market, by Type

    • 12.2 Southwest China Biologics & Biosimilars Market, by Application

    Chapter 13 Northwest China Biologics & Biosimilars Market Analysis

    • 13.1 Northwest China Biologics & Biosimilars Market, by Type

    • 13.2 Northwest China Biologics & Biosimilars Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Biotech Pharma

        • 14.1.1 Biotech Pharma Company Profile

        • 14.1.2 Biotech Pharma Biologics & Biosimilars Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck

        • 14.2.1 Merck Company Profile

        • 14.2.2 Merck Biologics & Biosimilars Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Gelgen Biopharma

        • 14.3.1 Gelgen Biopharma Company Profile

        • 14.3.2 Gelgen Biopharma Biologics & Biosimilars Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Changchun High Tech

        • 14.4.1 Changchun High Tech Company Profile

        • 14.4.2 Changchun High Tech Biologics & Biosimilars Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Teva

        • 14.5.1 Teva Company Profile

        • 14.5.2 Teva Biologics & Biosimilars Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 fizer

        • 14.6.1 fizer Company Profile

        • 14.6.2 fizer Biologics & Biosimilars Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 CP Guojian Pharmacy

        • 14.7.1 CP Guojian Pharmacy Company Profile

        • 14.7.2 CP Guojian Pharmacy Biologics & Biosimilars Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Mylan

        • 14.8.1 Mylan Company Profile

        • 14.8.2 Mylan Biologics & Biosimilars Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AbbVie

        • 14.9.1 AbbVie Company Profile

        • 14.9.2 AbbVie Biologics & Biosimilars Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Johnson & Johnson

        • 14.10.1 Johnson & Johnson Company Profile

        • 14.10.2 Johnson & Johnson Biologics & Biosimilars Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Sanofi

        • 14.11.1 Sanofi Company Profile

        • 14.11.2 Sanofi Biologics & Biosimilars Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Hospira

        • 14.12.1 Hospira Company Profile

        • 14.12.2 Hospira Biologics & Biosimilars Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Novo Nordisk

        • 14.13.1 Novo Nordisk Company Profile

        • 14.13.2 Novo Nordisk Biologics & Biosimilars Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Lilly

        • 14.14.1 Lilly Company Profile

        • 14.14.2 Lilly Biologics & Biosimilars Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Roche

        • 14.15.1 Roche Company Profile

        • 14.15.2 Roche Biologics & Biosimilars Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 3sbio

        • 14.16.1 3sbio Company Profile

        • 14.16.2 3sbio Biologics & Biosimilars Market Performance

        • 14.16.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Biologics & Biosimilars Industry Research Conclusions

    • 15.2 Biologics & Biosimilars Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Biologics & Biosimilars Industry Market Size (2018-2029)

    • Figure China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Non-Patented Biological Reagents (2018-2029)

    • Figure China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Hormone (2018-2029)

    • Figure China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Antibiotic (2018-2029)

    • Figure China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Biologics & Biosimilars Production Volume, Production Value and Growth Rate of Enzyme (2018-2029)

    • Figure China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

    • Figure China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Tumor (2018-2029)

    • Figure China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate of Hemophilia (2018-2029)

    • Figure North China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Central China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure South China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure East China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Biologics & Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Biologics & Biosimilars Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Biologics & Biosimilars Market Share by Type in 2018

    • Figure China Biologics & Biosimilars Market Share by Type in 2023

    • Figure China Biologics & Biosimilars Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Biologics & Biosimilars Production Volume and Growth Rate of Non-Patented Biological Reagents (2018-2023)

    • Figure China Biologics & Biosimilars Production Volume and Growth Rate of Hormone (2018-2023)

    • Figure China Biologics & Biosimilars Production Volume and Growth Rate of Antibiotic (2018-2023)

    • Figure China Biologics & Biosimilars Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Biologics & Biosimilars Production Volume and Growth Rate of Enzyme (2018-2023)

    • Figure China Biologics & Biosimilars Market Share by Application in 2018

    • Figure China Biologics & Biosimilars Market Share by Application in 2023

    • Figure China Biologics & Biosimilars Total Market Size and Growth Rate from Consumption End

    • Figure China Biologics & Biosimilars Market Size and Growth Rate of Diabetes (2018-2023)

    • Figure China Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular (2018-2023)

    • Figure China Biologics & Biosimilars Market Size and Growth Rate of Tumor (2018-2023)

    • Figure China Biologics & Biosimilars Market Size and Growth Rate of Other (2018-2023)

    • Figure China Biologics & Biosimilars Market Size and Growth Rate of Hemophilia (2018-2023)

    • Table China Biologics & Biosimilars Production Volume by Region (2018-2023)

    • Table China Biologics & Biosimilars Production Volume Share by Region (2018-2023)

    • Figure China Biologics & Biosimilars Production Volume Share by Region (2018-2023)

    • Table China Biologics & Biosimilars Production Value by Region (2018-2023)

    • Table China Biologics & Biosimilars Production Value Share by Region (2018-2023)

    • Figure China Biologics & Biosimilars Production Value Share by Region (2018-2023)

    • Table China Biologics & Biosimilars Sales Volume by Region (2018-2023)

    • Table China Biologics & Biosimilars Sales Volume Share by Region (2018-2023)

    • Figure China Biologics & Biosimilars Sales Volume Share by Region (2018-2023)

    • Table China Biologics & Biosimilars Sales Value by Region (2018-2023)

    • Table China Biologics & Biosimilars Sales Value Share by Region (2018-2023)

    • Figure China Biologics & Biosimilars Sales Value Share by Region (2018-2023)

    • Table North China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table North China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure North China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table North China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table North China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure North China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Central China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table Central China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Central China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table Central China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table Central China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Central China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table South China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table South China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure South China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table South China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table South China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure South China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table East China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table East China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure East China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table East China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table East China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure East China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northeast China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table Northeast China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northeast China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northeast China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table Northeast China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Southwest China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table Southwest China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Southwest China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table Southwest China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table Southwest China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northwest China Biologics & Biosimilars Production Volume by Type (2018-2023)

    • Table Northwest China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northwest China Biologics & Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northwest China Biologics & Biosimilars Sales Volume by Application (2018-2023)

    • Table Northwest China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Biologics & Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Biotech Pharma Company Profile

    • Table Biotech Pharma Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Gelgen Biopharma Company Profile

    • Table Gelgen Biopharma Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Changchun High Tech Company Profile

    • Table Changchun High Tech Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table fizer Company Profile

    • Table fizer Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table CP Guojian Pharmacy Company Profile

    • Table CP Guojian Pharmacy Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Hospira Company Profile

    • Table Hospira Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Lilly Company Profile

    • Table Lilly Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Biologics & Biosimilars Revenue, Price and Gross (2018-2023)

    • Table 3sbio Company Profile

    • Table 3sbio Biologics & Biosimilars Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US